Vanguard Group Inc Vbi Vaccines Inc Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.29 - $0.64 $6,214 - $13,714	21,429 Added 0.81%	2,664,204 $799,000
Q4 2022 Feb 10, 2023	BUY	$0.38 - $22.5 $778 - $46,080	2,048 Added 0.08%	2,642,775 $1.03 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $1.28 Million - $41 Million	-1,752,127 Reduced 39.89%	2,640,727 $1.86 Million
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $448,734 - $1.23 Million	-679,901 Reduced 13.4%	4,392,854 $3.55 Million
Q1 2022 May 13, 2022	SELL	$1.27 - $2.47 $14,178 - $27,575	-11,164 Reduced 0.22%	5,072,755 $8.42 Million
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $703,460 - $1.02 Million	-318,308 Reduced 5.89%	5,083,919 $11.9 Million
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $280,952 - $373,264	-100,340 Reduced 1.82%	5,402,227 $16.8 Million
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $14.4 Million - $22.9 Million	5,502,567 New	5,502,567 $18.4 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.